Oncopeptides AB Sustainability Reports

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of targeted therapies for difficult-to-treat cancers. The company utilizes its proprietary Peptide Drug Conjugate platform to develop compounds that deliver cytotoxic agents directly into cancer cells.

Sector: Manufacturing

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 549300J9WWQ5CBYQ1M77

FIGI: BBG004LT4BN0

19 reports from 2016 to 2025

• Oncopeptides AB 2025 Corporate Governance Report
• Oncopeptides AB 2025 Annual Report
• Oncopeptides AB 2024 Corporate Governance Report
• Oncopeptides AB 2024 Annual Report
• Oncopeptides AB 2023 Corporate Governance